ATE254921T1 - Desogestrel enthaltende tablette, kapsel oder granulat und verfahren zu deren herstellung - Google Patents

Desogestrel enthaltende tablette, kapsel oder granulat und verfahren zu deren herstellung

Info

Publication number
ATE254921T1
ATE254921T1 AT95201495T AT95201495T ATE254921T1 AT E254921 T1 ATE254921 T1 AT E254921T1 AT 95201495 T AT95201495 T AT 95201495T AT 95201495 T AT95201495 T AT 95201495T AT E254921 T1 ATE254921 T1 AT E254921T1
Authority
AT
Austria
Prior art keywords
capsule
tablet
production
desogestrel
granule containing
Prior art date
Application number
AT95201495T
Other languages
English (en)
Inventor
Haan Pieter De
Johannes G J Egberink
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE254921(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE254921T1 publication Critical patent/ATE254921T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95201495T 1994-06-08 1995-06-07 Desogestrel enthaltende tablette, kapsel oder granulat und verfahren zu deren herstellung ATE254921T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201625 1994-06-08

Publications (1)

Publication Number Publication Date
ATE254921T1 true ATE254921T1 (de) 2003-12-15

Family

ID=8216929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95201495T ATE254921T1 (de) 1994-06-08 1995-06-07 Desogestrel enthaltende tablette, kapsel oder granulat und verfahren zu deren herstellung

Country Status (18)

Country Link
US (1) US5709881A (de)
EP (1) EP0688565B2 (de)
JP (1) JP4302783B2 (de)
KR (1) KR100380841B1 (de)
CN (1) CN1057673C (de)
AT (1) ATE254921T1 (de)
AU (1) AU697512B2 (de)
BR (1) BR9502704A (de)
CA (1) CA2150642C (de)
DE (1) DE69532176T3 (de)
DK (1) DK0688565T4 (de)
ES (1) ES2210272T5 (de)
FI (1) FI952765A7 (de)
HU (1) HU218282B (de)
IL (1) IL113816A (de)
NZ (1) NZ272285A (de)
PT (1) PT688565E (de)
RU (1) RU2160107C2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212345B1 (de) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Oral wirksame 7-alpha-alkyl androgene
EP1204410B1 (de) * 1999-07-30 2012-09-12 Capsugel Belgium NV Multikomponent pharmazeutische dosierform
WO2003004001A1 (en) * 2001-07-06 2003-01-16 Lifecycle Pharma A/S Controlled agglomeration
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
CN105030792B (zh) * 2015-06-30 2017-08-25 上海交通大学 Desogestrel在制备抗结肠癌/ER阴性的Ah受体阳性的乳腺癌产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140915A (en) † 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
EP0300523B1 (de) 1987-07-06 1991-08-14 Akzo N.V. Pharmazeutische Dosierungseinheit zur Vorbeugung bzw. Behandlung von klimakterischen Beschwerden
EP0368373A1 (de) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Mehrphasisches kontrazeptives Präparat
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5395627A (en) † 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate

Also Published As

Publication number Publication date
RU2160107C2 (ru) 2000-12-10
JP4302783B2 (ja) 2009-07-29
KR100380841B1 (ko) 2003-08-14
DE69532176D1 (de) 2004-01-08
NZ272285A (en) 1996-08-27
EP0688565B2 (de) 2007-11-21
DK0688565T4 (da) 2008-03-17
HUT71491A (en) 1995-11-28
IL113816A (en) 1998-12-06
CA2150642C (en) 2008-04-22
CN1122226A (zh) 1996-05-15
ES2210272T3 (es) 2004-07-01
FI952765A0 (fi) 1995-06-06
HU9501654D0 (en) 1995-07-28
PT688565E (pt) 2004-03-31
AU697512B2 (en) 1998-10-08
ES2210272T5 (es) 2008-05-01
KR960000231A (ko) 1996-01-25
DE69532176T2 (de) 2004-08-12
AU2053195A (en) 1995-12-14
DE69532176T3 (de) 2008-06-12
DK0688565T3 (da) 2004-03-29
EP0688565A1 (de) 1995-12-27
HU218282B (en) 2000-07-28
US5709881A (en) 1998-01-20
EP0688565B1 (de) 2003-11-26
CA2150642A1 (en) 1995-12-09
CN1057673C (zh) 2000-10-25
HK1001996A1 (en) 1998-07-24
JPH07330610A (ja) 1995-12-19
BR9502704A (pt) 1996-03-05
FI952765L (fi) 1995-12-09
IL113816A0 (en) 1995-08-31
FI952765A7 (fi) 1995-12-09

Similar Documents

Publication Publication Date Title
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE113585T1 (de) Aminsäure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE58904674D1 (de) 4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt.
ATE296823T1 (de) Substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE3381680D1 (de) 1,4-dihydropyridincarbonsaeure-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3881950D1 (de) Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE69008566D1 (de) Pyridazin-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3675714D1 (de) Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3868309D1 (de) Imidazol-derivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammenstellungen und deren anwendung als arzneimittel.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATE254921T1 (de) Desogestrel enthaltende tablette, kapsel oder granulat und verfahren zu deren herstellung
DE58904595D1 (de) Neue alkylphosphonoserine, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel.
DE3583780D1 (de) 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3675378D1 (de) 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DE3684803D1 (de) Dihydropyridin-alkanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3675561D1 (de) Heterocyclische disulfide, verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten.
PT81409A (de) 1,3,4-thiadiazolderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
LU84492A1 (de) Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate
DE3667663D1 (de) Nitrosubstituierte heteroarylverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0688565

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0688565

Country of ref document: EP

REN Ceased due to non-payment of the annual fee